Development asset linked to INOVIO Pharmaceuticals in public FDA and regional records.
pharma · Anal Neoplasm · Lassa Fever · INO
INOVIO Pharmaceuticals
INOVIO PHARMACEUTICALS, INC.
INOVIO Pharmaceuticals drug portfolio — 8 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
660 West Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, US HQ
203 Employees
Public company Type
INO · NYSE Ticker
Company details
- Status
- Public
- HQ
- 660 West Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, US
- Employees
- 203
- Programs
- 46
- Drugs
- 8
- Patents
- 75
INOVIO Pharmaceuticals pipeline
Portfolio lens on 8 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
INOVIO Pharmaceuticals drug portfolio — 8 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to INOVIO Pharmaceuticals in public FDA and regional records.
-
diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv), poliomyelitis (inactivated) (ipv) and haemophilus influenzae type-b (hib) conjugate vaccine (adsorbed)
Antiinfectives for systemic use (J07)Antiinfectives for systemic use (J07) compound in INOVIO Pharmaceuticals's portfolio.
-
Development asset linked to INOVIO Pharmaceuticals in public FDA and regional records.
-
Development asset linked to INOVIO Pharmaceuticals in public FDA and regional records.
-
influenza vaccine (live attenuated, nasal)
Antiinfectives for systemic use (J07)Antiinfectives for systemic use (J07) compound in INOVIO Pharmaceuticals's portfolio.
-
Development asset linked to INOVIO Pharmaceuticals in public FDA and regional records.
-
Development asset linked to INOVIO Pharmaceuticals in public FDA and regional records.